PROACTIVELY PREVENT COVID-19 DISEASE BEFORE THE LUNAR NEW YEAR

The COVID-19 epidemic is still going on around the world. New SARS-CoV-2 virus variants have the potential to cause another outbreak of the disease. COVID-19 patients appear in areas throughout Vietnam.

According to the Ministry of Health, Vietnam had 132 cases of COVID-19 on December 28, 2022. Although the rate of hospitalization and death is low, we must be cautious when it comes to epidemic prevention. When the SARS-CoV-2 virus changes unpredictably, an epidemic is possible at any time. The majority of patients who become infected with the virus experience symptoms such as fever, cough, nausea, shortness of breath, and so on.

We need to stop the epidemic before the Lunar New Year arrives. Crowding is a favorable environment for the spread of infectious diseases. Please maintain a safe distance of at least one meter when speaking, wear a mask when entering crowded areas, wash your hands frequently with soap or an antiseptic solution, and cover your mouth when coughing or sneezing. If you have symptoms, get tested right away, and please isolate and treat yourself during the week you were infected with COVID 19.

On February 17, 2022, the Drug Administration of Vietnam and the Ministry of Health approved the distribution of Molravir 400, a drug used to treat COVID-19, a product manufactured by Boston Pharma and containing 400 mg Molnupiravir:

- Hard capsules that are colored (light-protective).

- Aluminum blister packaging (front and back): provides environmental protection (light, moisture).

Molravir 400 - Boston Pharma

Adults may be treated with oral tablets for COVID-19. As a specific antiviral drug prescribed by the Ministry of Health, patients may only take Molnupiravir 800 mg every 12 hours for five days. Patients must stop for three days because the virus has been destroyed. Furthermore, the body has produced antibodies to combat the virus's remnants.

Boston Pharma's Molravir 400 production line currently produces 2 million tablets per day. Products are distributed at reasonable prices so that people can easily purchase medicine.

Within 60 days, reinfection with COVID-19 is uncommon, and Molnupiravir can be used to treat subsequent reinfections. Molnupiravir is an active ingredient that prevents the SARS-CoV-2 virus from reproducing, lowering morbidity and mortality.

Happy Chinese New Year! Let us work together to protect your health and avert the COVID-19 epidemic.

Hotline: 19001910

Please contact us for further details: (+84) 938669659 - Head of International Sales Department (Phone call or Whatsapp)